Cargando…
Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing
BACKGROUND: Plazomicin (PLZ) is a next-generation aminoglycoside (AMG) stable against aminoglycoside-modifying enzymes (AME) that completed Phase 3 studies for complicated urinary tract infections and serious infections due to carbapenem-resistant Enterobacteriaceae (ENT). We evaluated the activity...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630809/ http://dx.doi.org/10.1093/ofid/ofx163.931 |
_version_ | 1783269298458853376 |
---|---|
author | Castanheira, Mariana Deshpande, Lalitagauri M Hubler, Cory M Mendes, Rodrigo E Serio, Alisa W Krause, Kevin M Flamm, Robert K |
author_facet | Castanheira, Mariana Deshpande, Lalitagauri M Hubler, Cory M Mendes, Rodrigo E Serio, Alisa W Krause, Kevin M Flamm, Robert K |
author_sort | Castanheira, Mariana |
collection | PubMed |
description | BACKGROUND: Plazomicin (PLZ) is a next-generation aminoglycoside (AMG) stable against aminoglycoside-modifying enzymes (AME) that completed Phase 3 studies for complicated urinary tract infections and serious infections due to carbapenem-resistant Enterobacteriaceae (ENT). We evaluated the activity of PLZ and AMGs against ENT collected in US hospitals during 2016. METHODS: A total of 2,097 ENT were susceptibility (S) tested by CLSI reference broth microdilution methods. E. coli, Klebsiella spp. Enterobacter spp., and P. mirabilis isolates displaying non-S MICs (CLSI criteria) for gentamicin (GEN), amikacin (AMK), and/or tobramycin (TOB) were submitted to WGS, de novo assembly and screening for AME genes. RESULTS: Against ENT, PLZ was more active than all 3 clinically available AMGs (Table). PLZ and AMK activities were stable regardless of the infection type; however, differences were observed for GEN and TOB. Bloodstream isolates displayed higher GEN MICs when compared with the other infection sites. TOB activity varied 4-fold, being higher for bloodstream and pneumonia infections and lower for skin/soft tissue and other/unknown specimens. Against 198 isolates carrying 1 or more AME-encoding genes detected among 208 AMG-non-S isolates, the activity of PLZ was 8- to 16-fold greater when compared with the activity of AMK and at least 16-fold higher than the activity of GEN or TOB. CONCLUSION: PLZ was active against ENT isolates from US hospitals regardless of infection type. PLZ displayed activity against isolates carrying AME genes that represent 12.0% of selected species. AME-carrying isolates were considerably more resistant to AMK, GEN, and TOB, highlighting the potential value of PLZ to treat infections caused by these organisms. This project has been funded under BARDA Contract No. HHSO100201000046C. DISCLOSURES: M. Castanheira, Achaogen: Research Contractor, Research grant; L. M. Deshpande, Achaogen: Research Contractor, Research grant; C. M. Hubler, Achaogen: Research Contractor, Research grant; R. E. Mendes, Achaogen: Research Contractor, Research grant; A. W. Serio, Achaogen: Employee, Salary; K. M. Krause, Achaogen: Employee, Salary; R. K. Flamm, Achaogen: Research Contractor, Research grant |
format | Online Article Text |
id | pubmed-5630809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56308092017-11-07 Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing Castanheira, Mariana Deshpande, Lalitagauri M Hubler, Cory M Mendes, Rodrigo E Serio, Alisa W Krause, Kevin M Flamm, Robert K Open Forum Infect Dis Abstracts BACKGROUND: Plazomicin (PLZ) is a next-generation aminoglycoside (AMG) stable against aminoglycoside-modifying enzymes (AME) that completed Phase 3 studies for complicated urinary tract infections and serious infections due to carbapenem-resistant Enterobacteriaceae (ENT). We evaluated the activity of PLZ and AMGs against ENT collected in US hospitals during 2016. METHODS: A total of 2,097 ENT were susceptibility (S) tested by CLSI reference broth microdilution methods. E. coli, Klebsiella spp. Enterobacter spp., and P. mirabilis isolates displaying non-S MICs (CLSI criteria) for gentamicin (GEN), amikacin (AMK), and/or tobramycin (TOB) were submitted to WGS, de novo assembly and screening for AME genes. RESULTS: Against ENT, PLZ was more active than all 3 clinically available AMGs (Table). PLZ and AMK activities were stable regardless of the infection type; however, differences were observed for GEN and TOB. Bloodstream isolates displayed higher GEN MICs when compared with the other infection sites. TOB activity varied 4-fold, being higher for bloodstream and pneumonia infections and lower for skin/soft tissue and other/unknown specimens. Against 198 isolates carrying 1 or more AME-encoding genes detected among 208 AMG-non-S isolates, the activity of PLZ was 8- to 16-fold greater when compared with the activity of AMK and at least 16-fold higher than the activity of GEN or TOB. CONCLUSION: PLZ was active against ENT isolates from US hospitals regardless of infection type. PLZ displayed activity against isolates carrying AME genes that represent 12.0% of selected species. AME-carrying isolates were considerably more resistant to AMK, GEN, and TOB, highlighting the potential value of PLZ to treat infections caused by these organisms. This project has been funded under BARDA Contract No. HHSO100201000046C. DISCLOSURES: M. Castanheira, Achaogen: Research Contractor, Research grant; L. M. Deshpande, Achaogen: Research Contractor, Research grant; C. M. Hubler, Achaogen: Research Contractor, Research grant; R. E. Mendes, Achaogen: Research Contractor, Research grant; A. W. Serio, Achaogen: Employee, Salary; K. M. Krause, Achaogen: Employee, Salary; R. K. Flamm, Achaogen: Research Contractor, Research grant Oxford University Press 2017-10-04 /pmc/articles/PMC5630809/ http://dx.doi.org/10.1093/ofid/ofx163.931 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Castanheira, Mariana Deshpande, Lalitagauri M Hubler, Cory M Mendes, Rodrigo E Serio, Alisa W Krause, Kevin M Flamm, Robert K Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing |
title | Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing |
title_full | Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing |
title_fullStr | Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing |
title_full_unstemmed | Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing |
title_short | Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing |
title_sort | activity of plazomicin against enterobacteriaceae isolates collected in the united states including isolates carrying aminoglycoside-modifying enzymes detected by whole genome sequencing |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630809/ http://dx.doi.org/10.1093/ofid/ofx163.931 |
work_keys_str_mv | AT castanheiramariana activityofplazomicinagainstenterobacteriaceaeisolatescollectedintheunitedstatesincludingisolatescarryingaminoglycosidemodifyingenzymesdetectedbywholegenomesequencing AT deshpandelalitagaurim activityofplazomicinagainstenterobacteriaceaeisolatescollectedintheunitedstatesincludingisolatescarryingaminoglycosidemodifyingenzymesdetectedbywholegenomesequencing AT hublercorym activityofplazomicinagainstenterobacteriaceaeisolatescollectedintheunitedstatesincludingisolatescarryingaminoglycosidemodifyingenzymesdetectedbywholegenomesequencing AT mendesrodrigoe activityofplazomicinagainstenterobacteriaceaeisolatescollectedintheunitedstatesincludingisolatescarryingaminoglycosidemodifyingenzymesdetectedbywholegenomesequencing AT serioalisaw activityofplazomicinagainstenterobacteriaceaeisolatescollectedintheunitedstatesincludingisolatescarryingaminoglycosidemodifyingenzymesdetectedbywholegenomesequencing AT krausekevinm activityofplazomicinagainstenterobacteriaceaeisolatescollectedintheunitedstatesincludingisolatescarryingaminoglycosidemodifyingenzymesdetectedbywholegenomesequencing AT flammrobertk activityofplazomicinagainstenterobacteriaceaeisolatescollectedintheunitedstatesincludingisolatescarryingaminoglycosidemodifyingenzymesdetectedbywholegenomesequencing |